2022-07-12 | Sale | Verve Therapeutics, Inc. VERV | 226,000 0.376% | $21.13 | $4.78M | -3.51% | ||
2022-07-01 | Sale | Verve Therapeutics, Inc. VERV | 77,550 0.1358% | $15.66 | $1.21M | +37.59% | ||
2022-06-30 | Sale | Verve Therapeutics, Inc. VERV | other | 18,810 0.0327% | $15.21 | $286,100 | +40.18% | |
2022-06-29 | Sale | Verve Therapeutics, Inc. VERV | 53,219 0.109% | $15.45 | $822,476 | +38.19% | ||
2022-03-09 | Sale | Verve Therapeutics, Inc. VERV | 7,942 0.0164% | $29.01 | $230,397 | -23.13% | ||
2022-02-09 | Sale | Verve Therapeutics, Inc. VERV | 10 percent owner | 26,380 0.0511% | $29.46 | $777,155 | -26.8% | |
2022-02-01 | Sale | Verve Therapeutics, Inc. VERV | 10 percent owner | 71,148 0.1467% | $29.04 | $2.07M | -19.9% | |
2022-01-27 | Sale | Verve Therapeutics, Inc. VERV | 10 percent owner | 17,966 0.0408% | $29.28 | $526,061 | -12.42% | |
2022-01-26 | Sale | Verve Therapeutics, Inc. VERV | 10 percent owner | 299,706 0.65% | $31.23 | $9.36M | -21.15% | |
2019-04-01 | Precision BioSciences, Inc. DTIL | 100,000 0.1888% | $16.00 | $1.6M | -35.24% | |||
2016-10-26 | Sale | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | 7,500 0.032% | $21.94 | $164,519 | +23.37% | |
2016-08-08 | Sale | Coherus BioSciences, Inc. CHRS | 200,000 0.4574% | $29.86 | $5.97M | -16.61% | ||
2016-08-05 | Sale | Coherus BioSciences, Inc. CHRS | 10 percent owner | 50,000 0.1137% | $28.78 | $1.44M | -13.29% | |
2016-08-04 | Sale | Coherus BioSciences, Inc. CHRS | 10 percent owner | 47,200 0.1088% | $28.16 | $1.33M | -9.97% | |
2016-05-17 | Sale | REGENXBIO Inc. RGNX | 18,300 0.069% | $12.41 | $227,103 | +39.42% | ||
2016-05-16 | Sale | REGENXBIO Inc. RGNX | 10 percent owner | 10,500 0.0386% | $11.86 | $124,534 | +41.54% | |
2016-05-13 | Sale | REGENXBIO Inc. RGNX | 10 percent owner | 5,530 0.0208% | $11.25 | $62,231 | +52.12% | |
2016-05-12 | Sale | REGENXBIO Inc. RGNX | 10 percent owner | 6,711 0.0251% | $10.85 | $72,833 | +56.08% | |
2016-05-11 | Sale | REGENXBIO Inc. RGNX | 10 percent owner | 14,189 0.0514% | $10.58 | $150,135 | +54.7% | |
2016-05-10 | Sale | REGENXBIO Inc. RGNX | 10 percent owner | 10,943 0.0417% | $10.08 | $110,318 | +70.07% |